Title:
AGENT FOR ENHANCING IMMUNITY TO CANCER BY USING Allergin-1 ANTAGONIST
Document Type and Number:
WIPO Patent Application WO/2017/038997
Kind Code:
A1
Abstract:
The present invention addresses the problem of providing a medicinal agent for suppressing the progression and recurrence of cancer and/or for treating cancer, the medicinal agent comprising a novel active ingredient having the effect of enhancing immunity to cancer. This Allergin-1 antagonist has the effect of enhancing immunity to cancer, and can be used for suppressing the progression and recurrence of cancer and/or for treating cancer. In particular, this Allergin-1 antagonist is useful for treating cancer patients for whom the therapeutic effects of anti-tumor immunotherapeutic agent are insufficient, or useful for cancer treatments in combination with anti-cancer drugs.
Inventors:
SHIBAYAMA SHIRO (JP)
ARIMA HIROSHI (JP)
SIMBO TAKUYA (JP)
ARIMA HIROSHI (JP)
SIMBO TAKUYA (JP)
Application Number:
PCT/JP2016/075887
Publication Date:
March 09, 2017
Filing Date:
September 02, 2016
Export Citation:
Assignee:
ONO PHARMACEUTICAL CO (JP)
International Classes:
A61K39/395; A61K38/00; A61K45/00; A61K45/06; A61P35/00; A61P35/02; A61P37/04; A61P43/00
Other References:
SATOKO TAHARA: "An immunoglobulin-like receptor, Allergin-1", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 245, no. 3, 2013, XP009509284
TATSUHIKO KODAMA: "Hirogaru ''Cha no Shizuku Sekken'' Higai", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 240, no. 4, 2012, XP009509563
See also references of EP 3345618A4
TATSUHIKO KODAMA: "Hirogaru ''Cha no Shizuku Sekken'' Higai", JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, vol. 240, no. 4, 2012, XP009509563
See also references of EP 3345618A4
Attorney, Agent or Firm:
AOKI, Atsushi et al. (JP)
Download PDF: